An Unbiased View of BMS-199264 hydrochloride
All enrolled sufferers who obtained a minimum of one particular dose of zosuquidar or placebo in the course of induction ended up monitored for the occurrence of adverse occasions (439 sufferers, 219 on zosuquidar and 210 on placebo). The most typical adverse situations were linked to the period of prolonged and substantial myelosuppression as is a